Announcements Trials
Browse Landscape

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Conditions

Turcot syndrome 1Lymphatic Metastasis 1

Interventions

pembrolizumab 8Nivolumab 6Ipilimumab 3toripalimab 2atezolizumab 2Specimen Handling 2Celecoxib 2relatlimab 1fludarabine phosphate 1fludarabine 1durvalumab 1denileukin diftitox 1camrelizumab 1avelumab 1XELOX 1Neoadjuvant Therapy 1Magnetic Resonance Spectroscopy 1Irinotecan 1Interleukin-2 1Induction Chemotherapy 1Immunotherapy 1Immune Checkpoint Inhibitors 1IMM-101 1E7777 fusion protein 1Docetaxel 1Diffusion Tensor Imaging 1DNA Mismatch Repair 1DEAE-Dextran 1Cyclophosphamide 1Colonoscopy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Turcot syndrome × DNA Mismatch Repair × 1 year × Clear all
NCT07625735 2026-06-04

MMR Status Modulates the Predictive Value of Lymphatic Invasion for Lymph Node Metastasis in Gastric Cancer

Shanghai Zhongshan Hospital

Not yet recruiting
3,000 enrolled

Turcot syndrome, Lymphatic Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡